AAAAAA

   
Results: 1-13 |
Results: 13
The hemostatic effects of warfarin titration in post CABG patients in comparison to placebo treatment
Authors: Walenga, JM Hoppensteadt, D Pifarre, R Fox, NL Forman, S Hunninghake, DB Campeau, L Herd, JA Hoogwerf, BJ Hickey, A Probstfield, JL Terrin, ML
Citation: Jm. Walenga et al., The hemostatic effects of warfarin titration in post CABG patients in comparison to placebo treatment, J THROMB TH, 11(2), 2001, pp. 143-149
Entry sites for coronary angiography and therapeutic interventions: From the proximal to the distal radial artery
Authors: Campeau, L
Citation: L. Campeau, Entry sites for coronary angiography and therapeutic interventions: From the proximal to the distal radial artery, CAN J CARD, 17(3), 2001, pp. 319-325
Effect of an aggressive lipid-lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the Post CoronaryArtery Bypass Graft Trial
Authors: White, CW Gobel, FL Campeau, L Knatterud, GL Forman, SA Forrester, JS Geller, NL Herd, JA Hickey, A Hoogwerf, BJ Hunninghake, DB Rosenberg, Y Terrin, ML
Citation: Cw. White et al., Effect of an aggressive lipid-lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the Post CoronaryArtery Bypass Graft Trial, CIRCULATION, 104(22), 2001, pp. 2660-2665
Lessons from the Post Coronary Artery Bypass Graft study in evaluating andcontrolling technical variability in angiographic trials
Authors: White, CW Campeau, L Canner, P Domanski, M Forrester, JS Gobel, FL Herd, JA Hoogwerf, BJ Hunninghake, DB Knatterud, GL LoPresti, F
Citation: Cw. White et al., Lessons from the Post Coronary Artery Bypass Graft study in evaluating andcontrolling technical variability in angiographic trials, AM J CARD, 87(1), 2001, pp. 40-43
Prognostic factors for atherosclerosis progression in saphenous vein grafts - The postcoronary artery bypass graft (post-CABG) trial
Authors: Domanski, MJ Borkowf, CB Campeau, L Knatterud, GL White, C Hoogwerf, B Rosenberg, Y Geller, NL
Citation: Mj. Domanski et al., Prognostic factors for atherosclerosis progression in saphenous vein grafts - The postcoronary artery bypass graft (post-CABG) trial, J AM COL C, 36(6), 2000, pp. 1877-1883
Lipid lowering and coronary bypass graft surgery
Authors: Campeau, L
Citation: L. Campeau, Lipid lowering and coronary bypass graft surgery, CURR OPIN C, 15(6), 2000, pp. 395-399
Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial
Authors: Knatterud, GL Rosenberg, Y Campeau, L Geller, NL Hunninghake, DB Forman, SA Forrester, JS Gobel, FL Herd, JA Hickey, A Hoogwerf, BJ Terrin, ML White, C
Citation: Gl. Knatterud et al., Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial, CIRCULATION, 102(2), 2000, pp. 157
Dr Paul P David - In memoriam
Authors: Campeau, L Bourassa, MG Dagenais, GR Lesperance, J
Citation: L. Campeau et al., Dr Paul P David - In memoriam, CAN J CARD, 15(5), 1999, pp. 518-519
Dr. Paul P. David - In memoriam
Authors: Campeau, L Bourassa, M Dagenais, GR Lesperance, J
Citation: L. Campeau et al., Dr. Paul P. David - In memoriam, REV ESP CAR, 52(8), 1999, pp. 639-640
The effect of aggressive and moderate lowering of LDL-cholesterol and low dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post coronary artery bypass graft trial
Authors: Alaupovic, P Fesmire, JD Hunnighake, D Domanski, M Forman, S Knatterud, GL Forrester, J Herd, JA Hoogwerf, B Campeau, L Gobel, FL
Citation: P. Alaupovic et al., The effect of aggressive and moderate lowering of LDL-cholesterol and low dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post coronary artery bypass graft trial, ATHEROSCLER, 146(2), 1999, pp. 369-379
Effects of aggressive cholesterol lowering and low-dose anticoagulation onclinical and angiographic outcomes in patients with diabetes - The post coronary artery bypass graft trial
Authors: Hoogwerf, BJ Waness, A Cressman, M Canner, J Campeau, L Domanski, M Geller, N Herd, A Hickey, A Hunninghake, DB Knatterud, GL White, C
Citation: Bj. Hoogwerf et al., Effects of aggressive cholesterol lowering and low-dose anticoagulation onclinical and angiographic outcomes in patients with diabetes - The post coronary artery bypass graft trial, DIABETES, 48(6), 1999, pp. 1289-1294
Aggressive cholesterol lowering delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors - NHLBI post coronary artery bypass graft clinical trial
Authors: Campeau, L Hunninghake, DB Knatterud, GL White, CW Domanski, M Forman, SA Forrester, JS Geller, NL Gobel, FL Herd, JA Hoogwerf, BJ Rosenberg, Y
Citation: L. Campeau et al., Aggressive cholesterol lowering delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors - NHLBI post coronary artery bypass graft clinical trial, CIRCULATION, 99(25), 1999, pp. 3241-3247
Safety of coronary arteriography in clinically stable patients following coronary bypass surgery
Authors: Gobel, FL Stewart, WJ Campeau, L Hickey, A Herd, JA Forman, S White, CW Rosenberg, Y
Citation: Fl. Gobel et al., Safety of coronary arteriography in clinically stable patients following coronary bypass surgery, CATHET CARD, 45(4), 1998, pp. 376-381
Risultati: 1-13 |